Managing chronic eye conditions requires precision, consistency, and patience. For millions of individuals diagnosed with open-angle glaucoma or ocular hypertension, daily topical eye drops are the standard defense against rising intraocular pressure (IOP). However, successfully administering these drops every single day is a hurdle that many patients quietly face.

The Everyday Struggle of Topical Eye Drops

While prescription eye drops effectively lower eye pressure to protect the optic nerve, getting them in properly can be surprisingly difficult. Patients frequently encounter several barriers with daily drop regimens:

• Physical Limitations: Conditions such as arthritis, hand tremors, or general joint stiffness can make squeezing small bottle tips nearly impossible.
• Administration Errors: Missing the eye entirely, contaminating the bottle tip, or accidentally applying multiple drops instead of one can compromise treatment.
• Complex Schedules: Remembering multiple types of drops at precise intervals throughout the day can lead to missed doses, especially for individuals managing memory disorders or busy schedules.
• Side Effects and Irritation: Preservatives and frequent liquid contact can sometimes lead to surface dryness, redness, and ocular discomfort.

When eye drops are missed or improperly administered, intraocular pressure can fluctuate dangerously, increasing the long-term risk of progressive vision loss.

Enter DURYSTA™: A Breakthrough Alternative

Recognizing the adherence challenges of traditional therapy, medical advancements have introduced new ways to protect vision. Approved as the first intracameral, biodegradable sustained-release implant, DURYSTA™ was designed to offer patients an alternative IOP-lowering option to topical eyedrops.

Roughly the size of a tiny grain of rice, the DURYSTA™ implant consists of a well-established class of glaucoma medication. During a quick, virtually painless in-office procedure that takes less than a minute, an eye care professional places the small, preservative-free plug directly inside the front chamber of the eye.

Once in place, the implant continuously and automatically releases medication to manage intraocular pressure over a span of several months (lasting 6 to 12 months in most patients). Because it is fully biodegradable, it dissolves naturally over time, eliminating any need for a removal procedure. It provides both patients and physicians reassurance that eye pressure remains consistently controlled without the daily routine of drops.

Is DURYSTA™ Right For Everyone?

While DURYSTA™ offers a liberating option for those struggling with conventional drops, it is not suitable for everyone. It is typically contraindicated in patients with Fuchs’ Dystrophy, a history of corneal transplants, aphakia, or a known hypersensitivity to bimatoprost. A comprehensive evaluation by a qualified ophthalmologist is necessary to determine candidacy.

Experience Modern Glaucoma Care at The Eye Center

If you or a loved one find daily eye drops to be a frustrating or overwhelming part of managing glaucoma, you do not have to navigate it alone. The Eye Center offers specialized evaluation and management options, including the administration of the DURYSTA™ implant.

To learn more about whether DURYSTA™ can simplify your treatment routine and help protect your long-term vision, reach out to the expert team at The Eye Center today to schedule a consultation.